Eventide Asset Management, LLC Mirum Pharmaceuticals, Inc. Transaction History
Eventide Asset Management, LLC
- $5.67 Billion
- Q3 2024
A detailed history of Eventide Asset Management, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 3,445,363 shares of MIRM stock, worth $143 Million. This represents 2.37% of its overall portfolio holdings.
Number of Shares
3,445,363
Previous 3,614,820
4.69%
Holding current value
$143 Million
Previous $124 Million
8.72%
% of portfolio
2.37%
Previous 2.18%
Shares
10 transactions
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$273 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$186 Million0.09% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$135 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$128 Million3.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.5MShares$104 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.53B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...